Human PDCD2/RP8/ZMYND7 ORF/cDNA clone-Lentivirus plasmid (NM_002598)
Cat. No.: pGMLP001712
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human PDCD2/RP8/ZMYND7 Lentiviral expression plasmid for PDCD2 lentivirus packaging, PDCD2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
PD-2/PDCD2/RP8 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP001712 |
Gene Name | PDCD2 |
Accession Number | NM_002598 |
Gene ID | 5134 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 1035 bp |
Gene Alias | RP8,ZMYND7 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCTGCCGCCGGGGCCAGGCCTGTGGAGCTGGGCTTCGCCGAGTCGGCGCCGGCGTGGCGACTGCGCAGCGAGCAGTTCCCCAGCAAGGTGGGCGGGCGGCCGGCATGGCTGGGCGCGGCCGGGCTGCCGGGGCCCCAGGCCCTGGCCTGCGAGCTGTGCGGCCGCCCGCTCTCCTTCCTGCTGCAGGTGTATGCGCCGCTGCCTGGCCGCCCGGACGCCTTCCACCGCTGCATCTTCCTCTTCTGCTGCCGCGAGCAGCCGTGCTGTGCCGGCCTGCGAGTTTTTAGGAATCAACTACCCAGGAAAAACGATTTTTACTCATATGAGCCACCTTCTGAGAATCCTCCCCCAGAAACAGGAGAATCAGTGTGTCTCCAGCTTAAGTCTGGTGCTCATCTCTGCAGGGTTTGTGGCTGTTTAGGCCCCAAAACGTGCTCCAGATGCCACAAAGCATATTACTGCAGCAAGGAGCATCAGACCCTAGACTGGAGATTGGGACATAAGCAGGCTTGTGCACAACCAGATCATCTGGACCATATAATTCCAGACCACAACTTCCTTTTTCCAGAATTTGAAATTGTAATAGAAACAGAAGATGAGATTATGCCTGAGGTTGTGGAAAAGGAAGATTACTCAGAGATTATAGGGAGCATGGGTGAAGCACTTGAGGAAGAACTGGATTCCATGGCAAAACATGAATCCAGGGAAGATAAAATTTTTCAGAAGTTTAAAACTCAGATAGCCCTTGAACCAGAACAGATTCTTAGATATGGCAGAGGTATTGCCCCCATCTGGATTTCTGGTGAAAATATTCCTCAAGAAAAGGATATTCCAGATTGCCCCTGTGGTGCCAAGAGAATATTGGAATTCCAGGTCATGCCTCAGCTCCTAAACTACCTGAAGGCTGACAGACTGGGCAAGAGCATTGACTGGGGCATCCTGGCTGTCTTCACCTGTGCTGAGAGCTGCAGCTTGGGTACTGGCTATACAGAAGAATTTGTGTGGAAGCAGGATGTAACAGATACACCGTAA |
ORF Protein Sequence | MAAAGARPVELGFAESAPAWRLRSEQFPSKVGGRPAWLGAAGLPGPQALACELCGRPLSFLLQVYAPLPGRPDAFHRCIFLFCCREQPCCAGLRVFRNQLPRKNDFYSYEPPSENPPPETGESVCLQLKSGAHLCRVCGCLGPKTCSRCHKAYYCSKEHQTLDWRLGHKQACAQPDHLDHIIPDHNFLFPEFEIVIETEDEIMPEVVEKEDYSEIIGSMGEALEEELDSMAKHESREDKIFQKFKTQIALEPEQILRYGRGIAPIWISGENIPQEKDIPDCPCGAKRILEFQVMPQLLNYLKADRLGKSIDWGILAVFTCAESCSLGTGYTEEFVWKQDVTDTP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T27736-Ab | Anti-PD-2 monoclonal antibody |
Target Antigen | GM-Tg-g-T27736-Ag | PD-2/PDCD2 protein |
ORF Viral Vector | pGMLP001712 | Human PDCD2 Lentivirus plasmid |
ORF Viral Vector | vGMLP001712 | Human PDCD2 Lentivirus particle |
Target information
Target ID | GM-T27736 |
Target Name | PD-2 |
Gene ID | 5134, 18567, 696380, 58934, 101084453, 475041, 512079, 100051773 |
Gene Symbol and Synonyms | Pcd2,PDCD2,RP-8,RP8,ZMYND7 |
Uniprot Accession | Q16342 |
Uniprot Entry Name | PDCD2_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000071994 |
Target Classification | Tumor-associated antigen (TAA) |
This gene encodes a nuclear protein expressed in a variety of tissues. Expression of this gene has been shown to be repressed by B-cell CLL/lymphoma 6 (BCL6), a transcriptional repressor required for lymph node germinal center development, suggesting that BCL6 regulates apoptosis by its effects on this protein. Alternative splicing results in multiple transcript variants and pseudogenes have been identified on chromosomes 9 and 12. [provided by RefSeq, Dec 2010]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.